Literature DB >> 21195174

Layer-by-layer assembly of poly(L-glutamic acid)/chitosan microcapsules for high loading and sustained release of 5-fluorouracil.

Shifeng Yan1, Jie Zhu, Zhichun Wang, Jingbo Yin, Yanzhen Zheng, Xuesi Chen.   

Abstract

Hollow polyelectrolyte microcapsules based on poly(l-glutamic acid) (PLGA) and chitosan (CS) with opposite charges were fabricated by layer-by-layer (LbL) assembly technique using melamine formaldehyde (MF) microparticles as sacrificial templates. The LbL assembly of polyelectrolytes and the resultant PLGA/CS microcapsules were characterized. A hydrophilic anticancer drug, 5-fluorouracil (5-FU), was chosen to investigate the loading and release properties of the microcapsules. The PLGA/CS microcapsules show high loading capacity of 5-FU under conditions of high drug concentration and salt adding. The high loading can be ascribed to spontaneous deposition of 5-FU induced by hydrogen bonding between 5-FU and PLGA/CS microcapsules. The PLGA/CS microcapsules show sustained release behavior. The release rate of 5-FU drastically slows down after loading in PLGA/CS microcapsules. The 5-FU release from PLGA/CS microcapsules can be best described using Ritger-Peppas or Baker-Londale models, indicating the diffusion mechanism of 5-FU release from the PLGA/CS microcapsules. In vitro cytotoxicity evaluation by the MTT assay shows good cell viability over the entire concentration range of PLGA/CS microcapsules. Therefore, the novel PLGA/CS microcapsules are expected to find application in drug delivery systems because of the properties of biodegradability, high loading, sustained release and cell compatibility.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21195174     DOI: 10.1016/j.ejpb.2010.12.031

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  13 in total

Review 1.  Halloysite nanotubes in analytical sciences and in drug delivery: A review.

Authors:  Meriem Fizir; Pierre Dramou; Nasiru Sintali Dahiru; Wang Ruya; Tao Huang; Hua He
Journal:  Mikrochim Acta       Date:  2018-07-25       Impact factor: 5.833

2.  Preparation of embolic NEMs loading capecitabine.

Authors:  Yuangang Liu; Peng He; Shibin Wang; Xuezhan Sun; Aizheng Chen
Journal:  J Mater Sci Mater Med       Date:  2012-10-10       Impact factor: 3.896

3.  Complexation of 5-Fluorouracil with β-Cyclodextrin and Sodium Dodecyl Sulfate: A Useful Tool for Encapsulating and Removing This Polluting Drug.

Authors:  Ana M T D P V Cabral; Ana C G Fernandes; Neuza A M Joaquim; Francisco Veiga; Sara P C Sofio; Isabel Paiva; Miguel A Esteso; M Melia Rodrigo; Artur J M Valente; Ana C F Ribeiro
Journal:  Toxics       Date:  2022-06-01

4.  Galactosylated chitosan/5-fluorouracil nanoparticles inhibit mouse hepatic cancer growth and its side effects.

Authors:  Ming-Rong Cheng; Qing Li; Tao Wan; Bing He; Jiang Han; Hou-Xiang Chen; Feng-Xiao Yang; Wei Wang; Hong-Zhi Xu; Tao Ye; Bing-Bing Zha
Journal:  World J Gastroenterol       Date:  2012-11-14       Impact factor: 5.742

Review 5.  Particles from preformed polymers as carriers for drug delivery.

Authors:  K Miladi; D Ibraheem; M Iqbal; S Sfar; H Fessi; A Elaissari
Journal:  EXCLI J       Date:  2014-02-03       Impact factor: 4.068

6.  In vitro and in vivo evaluation of cubosomes containing 5-fluorouracil for liver targeting.

Authors:  Mohamed Nasr; Mohamed K Ghorab; Ahmed Abdelazem
Journal:  Acta Pharm Sin B       Date:  2014-12-29       Impact factor: 11.413

7.  Synthesis of glycyrrhetinic acid-modified chitosan 5-fluorouracil nanoparticles and its inhibition of liver cancer characteristics in vitro and in vivo.

Authors:  Mingrong Cheng; Xiaoyan Gao; Yong Wang; Houxiang Chen; Bing He; Hongzhi Xu; Yingchun Li; Jiang Han; Zhiping Zhang
Journal:  Mar Drugs       Date:  2013-09-17       Impact factor: 5.118

8.  Glycyrrhetinic acid-modified chitosan nanoparticles enhanced the effect of 5-fluorouracil in murine liver cancer model via regulatory T-cells.

Authors:  Mingrong Cheng; Hongzhi Xu; Yong Wang; Houxiang Chen; Bing He; Xiaoyan Gao; Yingchun Li; Jiang Han; Zhiping Zhang
Journal:  Drug Des Devel Ther       Date:  2013-10-25       Impact factor: 4.162

9.  Optimized synthesis of glycyrrhetinic acid-modified chitosan 5-fluorouracil nanoparticles and their characteristics.

Authors:  Mingrong Cheng; Houxiang Chen; Yong Wang; Hongzhi Xu; Bing He; Jiang Han; Zhiping Zhang
Journal:  Int J Nanomedicine       Date:  2014-01-24

10.  Engineered silybin nanoparticles educe efficient control in experimental diabetes.

Authors:  Suvadra Das; Partha Roy; Rajat Pal; Runa Ghosh Auddy; Abhay Sankar Chakraborti; Arup Mukherjee
Journal:  PLoS One       Date:  2014-07-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.